Paul Tudor Jones II acquired 87.4 Thousand Neogenomics shares worth $703 Thousand. That's 0.01% of their equity portfolio (1019th largest holding). The first Neogenomics trade was made in Q2 2016. Since then Paul Tudor Jones II bought shares fifteen more times and sold shares on eight occasions. The investor's estimated purchase price is $1.28 Million, resulting in a loss of 45%.